Disulfiram for Effective Alcohol Dependence Management

Alli

Alli

Price from 41.00 $
Product dosage: 60mg
Package (num)Per pillPriceBuy
30$1.37$41.10 (0%)🛒 Add to cart
60$1.10$82.20 $66.16 (20%)🛒 Add to cart
90$1.01$123.31 $91.23 (26%)🛒 Add to cart
120$0.98$164.41 $117.29 (29%)🛒 Add to cart
180$0.94$246.61 $168.42 (32%)🛒 Add to cart
270$0.90$369.92 $243.61 (34%)🛒 Add to cart
360
$0.88 Best per pill
$493.23 $317.79 (36%)🛒 Add to cart
Synonyms

Similar products

Disulfiram is a clinically proven pharmacotherapy used as an integral component in the comprehensive management of chronic alcohol dependence. It functions as an alcohol-aversion agent by inhibiting the enzyme aldehyde dehydrogenase, leading to an accumulation of acetaldehyde upon ethanol consumption. This produces a highly unpleasant physiological reaction, which serves as a powerful psychological deterrent against alcohol intake. Administered under medical supervision, it is indicated for supportive treatment in motivated patients committed to maintaining abstinence within a structured therapeutic program.

Features

  • Contains disulfiram as the active pharmaceutical ingredient
  • Available in 250 mg and 500 mg oral tablets
  • Functions as an aldehyde dehydrogenase inhibitor
  • Requires consistent daily administration for maintained efficacy
  • Prescription-only medication requiring healthcare supervision
  • Compatible with most comprehensive addiction treatment protocols

Benefits

  • Creates a strong psychological deterrent against alcohol consumption through aversive conditioning
  • Supports long-term abstinence when combined with counseling and behavioral therapy
  • Provides a tangible pharmacological tool to reinforce patient commitment to sobriety
  • Reduces frequency of relapse episodes in motivated individuals
  • Helps reestablish normal metabolic patterns disrupted by chronic alcohol use
  • Contributes to improved overall health outcomes through sustained abstinence

Common use

Disulfiram is primarily indicated as an adjunctive therapy in the management of alcohol dependence in patients who wish to maintain a state of enforced sobriety. It is prescribed for individuals who have undergone detoxification and are committed to complete abstinence within a supervised treatment program. The medication is typically incorporated into comprehensive treatment plans that include psychological support, counseling, and ongoing medical monitoring. Clinical use requires thorough patient education regarding the consequences of alcohol consumption while medicated and careful patient selection to ensure appropriate motivation and understanding.

Dosage and direction

The initial dosage is typically 500 mg daily for the first one to two weeks, administered as a single dose in the morning. Maintenance dosage is usually 250 mg daily (range 125-500 mg), adjusted based on patient response and tolerance. The medication should be taken at the same time each day, preferably in the morning unless otherwise directed. Treatment should not be initiated until the patient has abstained from alcohol for at least 12 hours and preferably 24 hours. Dosage adjustments should be made under strict medical supervision based on individual patient response and tolerance.

Precautions

Patients must be thoroughly educated about the disulfiram-ethanol reaction and must avoid all forms of alcohol, including medications, foods, and toiletries containing alcohol. Regular liver function monitoring is essential due to potential hepatotoxicity. Baseline and periodic follow-up assessments of hepatic, hematological, and neurological status are recommended. Use with caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, hepatic impairment, or cardiovascular disease. Patients should carry identification indicating their disulfiram therapy.

Contraindications

Disulfiram is contraindicated in patients with severe myocardial disease or coronary occlusion, psychosis, hypersensitivity to disulfiram or other thiuram derivatives, and those who have recently metronidazole therapy. It is contraindicated in patients without their full knowledge or consent, and in those who are likely to drink alcohol despite understanding the consequences. Additional contraindications include pregnancy, severe hepatic impairment, and concomitant use with alcohol-containing preparations.

Possible side effects

Common side effects include drowsiness, fatigue, headache, metallic or garlic-like aftertaste, and skin eruptions. Less frequently reported effects include impotence, optic neuritis, peripheral neuropathy, and psychiatric symptoms. The most significant adverse effect is the disulfiram-ethanol reaction, characterized by flushing, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. Severe reactions may include respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death.

Drug interaction

Disulfiram inhibits several hepatic enzymes, particularly CYP2E1, potentially increasing plasma concentrations of phenytoin, warfarin, diazepam, chlordiazepoxide, and certain tricyclic antidepressants. Concurrent use with metronidazole may produce psychotic reactions. Interaction with isoniazid may cause unsteady gait or significant behavioral changes. Disulfiram may enhance the effects of caffeine and prolong the elimination of theophylline. Concomitant use with alcohol-containing medications or preparations must be strictly avoided.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one. Consistent daily administration is crucial for maintaining the aversive barrier against alcohol consumption.

Overdose

Symptoms of overdose may include nausea, vomiting, dizziness, ataxia, and in severe cases, neurological symptoms such as extrapyramidal reactions, seizures, or coma. Management involves immediate discontinuation of the medication, gastric lavage if ingestion was recent, and supportive care including monitoring of vital signs and symptomatic treatment. There is no specific antidote for disulfiram overdose. Hemodialysis may be considered in severe cases, though its efficacy is limited.

Storage

Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Keep container tightly closed and protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly discard any unused medication according to specific disposal instructions.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Disulfiram is a prescription medication that must be used under appropriate medical supervision. Patients should consult with qualified healthcare professionals for proper diagnosis, treatment recommendations, and monitoring. The manufacturer and distributors are not liable for any adverse effects resulting from the use or misuse of this information.

Reviews

Clinical studies demonstrate that disulfiram, when used as part of a comprehensive treatment program, significantly improves abstinence rates compared to placebo. Patient outcomes are most favorable when combined with psychosocial support and regular monitoring. Success rates vary considerably based on patient motivation, adherence to treatment, and the quality of accompanying therapeutic support. Many addiction specialists report that properly selected patients experience substantially reduced relapse rates and improved quality of life with disulfiram therapy.